Case Report: Thrombotic-Thrombocytopenic Purpura Following Ipilimumab and Nivolumab Combination Immunotherapy for Metastatic Melanoma

Autor: W. J. Mullally, F. J. Cooke, I. M. Crosbie, S. Kumar, V. E. Abernethy, E. J. Jordan, M. O’Connor, A. M. Horgan, R. Landers, J. Naidoo, P. M. Calvert

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

A man in his early 50s presented with small bowel obstruction, requiring emergency laparoscopic small bowel resection for the metastatic melanoma of the jejunum with no identifiable primary lesion. One week after his first treatment with ipilimumab a

Externí odkaz: https://doaj.org/article/424d3ddeba0d47e6a3157ac366348eab

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

Autor: Vermij, L., Jobsen, J.J., Leon-Castillo, A., Brinkhuis, M., Roothaan, S., Powell, M.E., Boer, S.M. de, Khaw, P., Mileshkin, L.R., Fyles, A., Leary, A., Genestie, C., Jnrgenliemk-Schulz, I.M., Crosbie, E.J., Mackay, H.J., Nijman, H.W., Nout, R.A., Smit, V.T.H.B.M., Creutzberg, C.L., Horeweg, N., Bosse, T., TransPORTEC Consortium

Publikováno v: Vermij, L, Jobsen, J J, León-Castillo, A, Brinkhuis, M, Roothaan, S, Powell, M E, De boer, S M, Khaw, P, Mileshkin, L R, Fyles, A, Leary, A, Genestie, C, Jürgenliemk-Schulz, I M, Crosbie, E J, Mackay, H J, Nijman, H W, Nout, R A, Smit, V T H B M, Creutzberg, C L, Horeweg, N, Bosse, T & De boer, S M 2023, ' Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry ', British Journal of Cancer . https://doi.org/10.1038/s41416-023-02141-0

Background Risk-assessment of endometrial cancer (EC) is based on clinicopathological factors and molecular subgroup. It is unclear whether adding hormone receptor expression, L1CAM expression or CTNNB1 status yields prognostic refinement. Methods Pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bad7b755656c5121f11cc6c3a4a7c4f
https://hdl.handle.net/1887/3630351